This page shows the latest Destiny Pharma news and features for those working in and with pharma, biotech and healthcare.
The former head of research at Pfizer's European operations will be medical director at Destiny. ... Anti-microbial drug development company Destiny Pharma has appointed ex-Pfizer research head Dr David Roblin as medical director.
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Step 1: From history to destiny. Although, in theory, firms can choose between any of the 26 business models shown in figure 1, in practice they are constrained by their history. ... to, for example, Sun Pharma and vice-versa.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Nick Rodgers joins Destiny Pharma. Clinical stage biotech Destiny Pharma has announced that Nick Rodgers will join the company as its independent non-executive director, effective immediately. ... Sir Nigel Rudd, chairman of Destiny Pharma, said:
Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate. ... Nigel Rudd, non-executive chairman of Destiny Pharma, said: “I am delighted to welcome Neil Clark as chief
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...